Missed out on this year’s top S&P 500 stocks? Analysts are already offering up their ideas on which stocks will rule in 2025.
↑
X
Beating The Market: How To Find Outperforming Stocks
Ten S&P 500 stocks — including Moderna (MRNA), Biogen (BIIB) and Micron Technology (MU) — are seen jumping more than 43% in the next 12 months, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. That’s the highest gain expected from any S&P 500 stocks.
Seeing this level of bullishness for these stocks is noteworthy. Analysts are already very positive for 2025. S&P 500 stocks, on average, are seen gaining more than 9% in 12 months.
“Potential upside could come from lower rates, productivity gains, and confirmation of market-friendly policies from the new administration,” said Jeff Buchbinder, chief equity strategist at LPL Financial.
Finding The Top S&P 500 Stocks Of 2025
Analysts’ hopes are highest for vaccine maker Moderna.
The stock is expected to soar more than 80% in 12 months to 75.77 a share. That would be a big surprise given that shares sank 58% this year to 41.57 apiece. Moderna stock carries an RS Rating of just 3.
There are some glimmers of fundamental strength, though. Analysts think the drugmaker’s profit will rise 24% this year and 4% in 2025.
Another health care play is analysts’ No. 2 favorite stock: Biogen. Shares of the biotech firm are down nearly 40% this year for a rock-bottom RS Rating. And the Composite Rating is just 25.
And yet, analysts think Biogen’s stock will jump 61% in 12 months to 75.77 a share. They must see something not in the estimates. The company’s earnings per share are seen dropping 2% in 2025.
More Than Just Health Care
But don’t think analysts only like beaten-down health care S&P 500 stocks. Analysts are also bullish on memory-chip maker Micron.
Shares are expected to gain nearly 49% in the next 12 months to 145.92. That gain would be on top of a nearly 15% rise in 2024.
It goes without saying that these are just estimates. And estimates are often wrong. But when you see bullishness amid an already bullish crowd, it may pay to listen.
Analysts’ Top Picks For 2025
Based on 12-month price targets
| Company | Ticker | Implied 12-month upside | Sector |
|---|---|---|---|
| Moderna | MRNA | 82.7% | Health Care |
| Biogen | BIIB | 60.9% | Health Care |
| AES | AES | 49.3% | Utilities |
| Micron Technology | MU | 48.7% | Information Technology |
| Devon Energy | DVN | 47.0% | Energy |
| Celanese | CE | 46.8% | Materials |
| Advanced Micro Devices | AMD | 44.3% | Information Technology |
| Centene | CNC | 44.1% | Health Care |
| APA | APA | 44.0% | Energy |
| Caesars Entertainment | CZR | 43.5% | Consumer Discretionary |
Follow Matt Krantz on X (Twitter) @mattkrantz
YOU MAY ALSO LIKE:
